Clinical Trials Directory

Trials / Unknown

UnknownNCT02318641

Measurement of the Oxygen Saturation in the Retinal Vessels With Oxymap

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Kagawa University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Retinal oximetry can be measured with newly developed Oxymap (Oxymap ehf, Reykjavik, Iceland). Briefly, the device simultaneously acquires digital images at two wavelengths and automatically tracks retinal vessels on both images. Retinal vessel oxygen saturation is estimated by spectrophotometric analysis of light reflected from retinal vessels and from the immediately surrounding retina. Oxygen saturation measurements are made on major temporal arteries and veins. Briefly, the first and second degree vessels are used, with the addition of third degree vessels in images where peripapillary haemorrhage prevented analysis close to the optic disc. Vessel segments chosen for analysis are used consistently for consecutive measurements in the same retina.

Detailed description

Retinal oximetry can be measured with newly developed Oxymap (Oxymap ehf, Reykjavik, Iceland). Briefly, the device simultaneously acquires digital images at two wavelengths and automatically tracks retinal vessels on both images. Retinal vessel oxygen saturation is estimated by spectrophotometric analysis of light reflected from retinal vessels and from the immediately surrounding retina. Oxygen saturation measurements are made on major temporal arteries and veins. Briefly, the first and second degree vessels are used, with the addition of third degree vessels in images where peripapillary haemorrhage prevented analysis close to the optic disc. Vessel segments chosen for analysis are used consistently for consecutive measurements in the same retina. Retinal oximetry in various chorioretinal diseases will be measured with Oxymap.

Conditions

Interventions

TypeNameDescription
DEVICEoximetryRetinal oximetry will be performed with Oxymap.

Timeline

Start date
2014-12-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2014-12-17
Last updated
2018-03-07

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02318641. Inclusion in this directory is not an endorsement.